EE315 Cost-Effectiveness Analysis of Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes in China
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.562
https://www.valueinhealthjournal.com/article/S1098-3015(22)02766-8/fulltext
Title :
EE315 Cost-Effectiveness Analysis of Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02766-8&doi=10.1016/j.jval.2022.09.562
First page :
Section Title :
Open access? :
No
Section Order :
10092